Table 1 Characteristics of all investigated patients
From: Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection
Characteristics of all patients | ||
|---|---|---|
Male | Female | |
Number | N = 231 | N = 310 |
Age | 43.5 ± 13.0 (18.3-77 years) | 43. 5 ± 12.2 (18.7–76.1 years) |
Mild diseasee WHO 1-2A | 128 | 192 |
Moderate disease WHO 2B-3 | 103 | 118 |
Severe disease WHO > 3 | 0 | 0 |
Mortality | 0 | 0 |
ECOG performance status prior SARS-CoV-2 infection | 0 | 0 |
Characteristics of patients infected during the 1st wave with SARS-CoV-2 (25th January 2020 until 16th May 2020) | ||
|---|---|---|
Male | Female | |
Number | N = 91 | N = 88 |
Age | 42.9 ± 13.3 (19.7–76.8 years) | 45.3 ± 13.7 (19.9–79.5 years) |
Mild disease WHO 1-2A | 39 | 47 |
Moderate disease WHO 2B-3 | 52 | 41 |
Severe disease WHO > 3 | 0 | 0 |
Mortality | 0 | 0 |
ECOG performance status prior SARS-CoV-2 infection | 0 | 0 |
Characteristics of patients infected during the 2nd wave with SARS-CoV-2 (19th May 2020 until 30th January 2021) | ||
|---|---|---|
Male | Female | |
Number | N = 140 | N = 222 |
Age | 43.3 ± 13.2(18.3-77 years) | 43.5 + 13.5 (18.7–79.5 years) |
Mild disease WHO 1-2A | 89 | 145 |
Moderate disease WHO 2B-3 | 51 | 77 |
Severe disease WHO > 3 | 0 | 0 |
Mortality | 0 | 0 |
ECOG performance status prior SARS-CoV-2 infection | 0 | 0 |